Ronald W Wood Selected Research

Biomarkers (Surrogate Marker)

1/2018	Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.
1/2016	Relationship Between Lymph Node Volume and Pain Following Certolizumab Therapy for Rheumatoid Arthritis Flare: A Pilot Study.
1/2013	Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritis.
6/2012	Validation of 3-dimensional ultrasound versus magnetic resonance imaging quantification of popliteal lymph node volume as a biomarker of erosive inflammatory arthritis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald W Wood Research Topics

Disease

8	Arthritis (Polyarthritis) 01/2019 - 08/2011
6	Rheumatoid Arthritis 01/2020 - 01/2013
5	Synovitis 01/2020 - 01/2013
4	Inflammation (Inflammations) 10/2021 - 01/2013
3	Pain (Aches) 10/2021 - 09/2005
3	Neoplasms (Cancer) 08/2012 - 06/2006
2	Vulvodynia 10/2021 - 09/2005
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2015 - 06/2006
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 11/2012 - 06/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 08/2012 - 06/2006
1	COVID-19 11/2021
1	Cystitis 01/2020
1	Hematuria 01/2020
1	Avian Reticuloendotheliosis 12/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Lower Urinary Tract Symptoms 11/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Arthralgia (Joint Pain) 01/2016
1	Urinary Retention 02/2015
1	Osteoarthritis 03/2014
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2013
1	Chronic Pain 01/2013
1	Disease Progression 11/2012
1	Hyperalgesia 09/2005
1	Vulvar Vestibulitis 09/2005
1	Urethritis 08/2004
1	Bradycardia 12/2003
1	Infections 10/2002

Drug/Important Bio-Agent (IBA)

8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 08/2011
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020 - 04/2012
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2012
2	Estrogens (Estrogen)FDA Link 11/2018 - 02/2015
2	CytokinesIBA 01/2018 - 01/2013
2	Testosterone (Sustanon)FDA Link 02/2015 - 11/2012
1	AntibodiesIBA 11/2021
1	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 10/2021
1	Dinoprostone (PGE2)FDA Link 10/2021
1	LipidsIBA 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Transcription Factor RelAIBA 12/2019
1	N 30IBA 01/2019
1	AndrogensIBA 11/2018
1	SaltsIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2017
1	ferulic acid (sodium ferulate)IBA 03/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2016
1	Estrogen ReceptorsIBA 02/2015
1	Selective Estrogen Receptor Modulators (SERM)IBA 02/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2014
1	Voltage-Gated Sodium ChannelsIBA 01/2013
1	Hormones (Hormone)IBA 11/2012
1	Histone Deacetylase InhibitorsIBA 08/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 08/2012
1	Vorinostat FDA Link 08/2012
1	Tumor Viral Antigens (Large T Antigen)IBA 06/2006
1	Uroplakin IIIBA 06/2006
1	Contrast MediaIBA 06/2006
1	Pain-FreeIBA 09/2005
1	Capsaicin (Zostrix)FDA Link 09/2005
1	Acetic Acid (Vinegar)FDA LinkGeneric 08/2004
1	anhydroecgonine methyl ester (methylecgonidine)IBA 12/2003

Therapy/Procedure

9	Therapeutics 10/2021 - 01/2013
1	Intraperitoneal Injections 01/2020
1	Nephrectomy 04/2012
1	Ligation 06/2006
1	Injections 09/2005
1	Catheters 10/2002